Essential Knowledge Update 2022.1 consists of four modules covering new and changing knowledge on:

Essential Knowledge Update 2022.1 consists of four modules covering new and changing knowledge on:
Essential Knowledge Update 16 consists of eight modules covering new and changing knowledge on
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are a class of drugs initially developed to treat type 2 diabetes and are now becoming more widely used for obesity. They work by mimicking the actions of the GLP-1 hormone, which is released by the gut after eating. GPs will be used to prescribing them for type 2 diabetes, but less so for obesity.
In this podcast, Dr Thomas Round discusses the evolving role of GLP1-RA in obesity, the benefits and potential side effects, the role of the GP, and the latest NICE guidance in this area with Dr Stephanie DiGiorgio, an urgent care GP with a specialist interest in obesity.
|
This course provides a variety of resources (grouped by topic and format e.g. eLearning, guidelines, courses and books) on the subject of gynaecology and breast. Topics include:
|